MANNKIND CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.665 USD | -0.11% |
|
+0.43% | +27.75% |
| May. 29 | MannKind Agrees to Cross License Deal With Pulmatrix | MT |
| May. 29 | Pulmatrix, Inc. Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MANNKIND CORPORATION | Bio Therapeutic Drugs | -0.43% | +0.43% | +27.75% | +7.64% | +278.05% | 1.27B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- MNKD Stock
- Charts MannKind Corporation
- Comparison Chart
